APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.
Ken Herrmann, MD, MBA, from the Universitätsklinikum Essen (Germany), and Johannes Czernin, MD, from the David Geffen School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback